Immunomodulatory effects of adipose-derived stem cells: Fact or fiction?

Angelo A. Leto Barone, Saami Khalifian, W. P.Andrew Lee, Gerald Brandacher

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Adipose-derived stromal cells (ASCs) are often referred to as adipose-derived stem cells due to their potential to undergo multilineage differentiation. Their promising role in tissue engineering and ability to modulate the immune system are the focus of extensive research. A number of clinical trials using ASCs are currently underway to better understand the role of such cell niche in enhancing or suppressing the immune response. If governable, such immunoregulatory role would find application in several conditions in which an immune response is present (i.e., autoimmune conditions) or feared (i.e., solid organ or reconstructive transplantation). Although allogeneic ASCs have been shown to prevent acute GvHD in both preclinical and clinical studies, their potential warrants further investigation. Well-designed and standardized clinical trials are necessary to prove the role of ASCs in the treatment of immune disorders or prevention of tissue rejection. In this paper we analyze the current literature on the role of ASCs in immunomodulation in vitro and in vivo and discuss their potential in regulating the immune system in the context of transplantation.

Original languageEnglish (US)
Article number383685
JournalBioMed Research International
Volume2013
DOIs
StatePublished - Oct 7 2013
Externally publishedYes

Fingerprint

Immune system
Stromal Cells
Stem cells
Stem Cells
Tissue engineering
Tissue
Immune System
Transplantation
Clinical Trials
Immunomodulation
Immune System Diseases
Tissue Engineering
Research

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Immunomodulatory effects of adipose-derived stem cells : Fact or fiction? / Leto Barone, Angelo A.; Khalifian, Saami; Lee, W. P.Andrew; Brandacher, Gerald.

In: BioMed Research International, Vol. 2013, 383685, 07.10.2013.

Research output: Contribution to journalReview article

Leto Barone, Angelo A. ; Khalifian, Saami ; Lee, W. P.Andrew ; Brandacher, Gerald. / Immunomodulatory effects of adipose-derived stem cells : Fact or fiction?. In: BioMed Research International. 2013 ; Vol. 2013.
@article{8265b37891ac4d1083b3391c084ffefe,
title = "Immunomodulatory effects of adipose-derived stem cells: Fact or fiction?",
abstract = "Adipose-derived stromal cells (ASCs) are often referred to as adipose-derived stem cells due to their potential to undergo multilineage differentiation. Their promising role in tissue engineering and ability to modulate the immune system are the focus of extensive research. A number of clinical trials using ASCs are currently underway to better understand the role of such cell niche in enhancing or suppressing the immune response. If governable, such immunoregulatory role would find application in several conditions in which an immune response is present (i.e., autoimmune conditions) or feared (i.e., solid organ or reconstructive transplantation). Although allogeneic ASCs have been shown to prevent acute GvHD in both preclinical and clinical studies, their potential warrants further investigation. Well-designed and standardized clinical trials are necessary to prove the role of ASCs in the treatment of immune disorders or prevention of tissue rejection. In this paper we analyze the current literature on the role of ASCs in immunomodulation in vitro and in vivo and discuss their potential in regulating the immune system in the context of transplantation.",
author = "{Leto Barone}, {Angelo A.} and Saami Khalifian and Lee, {W. P.Andrew} and Gerald Brandacher",
year = "2013",
month = "10",
day = "7",
doi = "10.1155/2013/383685",
language = "English (US)",
volume = "2013",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Immunomodulatory effects of adipose-derived stem cells

T2 - Fact or fiction?

AU - Leto Barone, Angelo A.

AU - Khalifian, Saami

AU - Lee, W. P.Andrew

AU - Brandacher, Gerald

PY - 2013/10/7

Y1 - 2013/10/7

N2 - Adipose-derived stromal cells (ASCs) are often referred to as adipose-derived stem cells due to their potential to undergo multilineage differentiation. Their promising role in tissue engineering and ability to modulate the immune system are the focus of extensive research. A number of clinical trials using ASCs are currently underway to better understand the role of such cell niche in enhancing or suppressing the immune response. If governable, such immunoregulatory role would find application in several conditions in which an immune response is present (i.e., autoimmune conditions) or feared (i.e., solid organ or reconstructive transplantation). Although allogeneic ASCs have been shown to prevent acute GvHD in both preclinical and clinical studies, their potential warrants further investigation. Well-designed and standardized clinical trials are necessary to prove the role of ASCs in the treatment of immune disorders or prevention of tissue rejection. In this paper we analyze the current literature on the role of ASCs in immunomodulation in vitro and in vivo and discuss their potential in regulating the immune system in the context of transplantation.

AB - Adipose-derived stromal cells (ASCs) are often referred to as adipose-derived stem cells due to their potential to undergo multilineage differentiation. Their promising role in tissue engineering and ability to modulate the immune system are the focus of extensive research. A number of clinical trials using ASCs are currently underway to better understand the role of such cell niche in enhancing or suppressing the immune response. If governable, such immunoregulatory role would find application in several conditions in which an immune response is present (i.e., autoimmune conditions) or feared (i.e., solid organ or reconstructive transplantation). Although allogeneic ASCs have been shown to prevent acute GvHD in both preclinical and clinical studies, their potential warrants further investigation. Well-designed and standardized clinical trials are necessary to prove the role of ASCs in the treatment of immune disorders or prevention of tissue rejection. In this paper we analyze the current literature on the role of ASCs in immunomodulation in vitro and in vivo and discuss their potential in regulating the immune system in the context of transplantation.

UR - http://www.scopus.com/inward/record.url?scp=84884891849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884891849&partnerID=8YFLogxK

U2 - 10.1155/2013/383685

DO - 10.1155/2013/383685

M3 - Review article

C2 - 24106704

AN - SCOPUS:84884891849

VL - 2013

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 383685

ER -